and papillary renal cell carcinoma. The data supporting the validity of nuclear grading for chromophobe carcinoma is not well estab-Presented at ''Diagnosis and Prognosis of Renal lished, but it seems reasonable to grade these tumors for ongoing
Classification of renal cell carcinoma : Workgroup No. 1
✍ Scribed by Stephan Störkel; John N. Eble; K. Adlakha; Mahul Amin; Michael L. Blute; David G. Bostwick; M. Darson; Brett Delahunt; K. Iczkowski
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 40 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
I n developing this proposal, the authors applied these principles:
- The classification must be based on morphology yet be in line with the genetic facts as they are presently understood, and in line with the evolution of the neoplasms. 2. The terms should be simple, unambiguous, and reflect a salient morphologic feature of the neoplasm. 3. The terms should be consistent with historic usage when possible, but when the meaning has changed significantly, they should be replaced with a new term. 4. A term is not a description and cannot encompass all of the morphologic variations of a neoplasm. The proposed classifications follows.
Benign Neoplasms
- Papillary adenoma is the most common neoplasm of the renal tubular epithelium and is a frequent incidental finding in adult kidneys. Most are õ3 mm. Lesions õ5 mm should be considered papillary adenoma. Their microscopic morphology resembles low grade papillary renal cell carcinoma to the extent that there are
no reliable cytologic criteria to distinguish individual examples from small carcinoma. That they are benign is inferred from their Presented at ''Diagnosis and Prognosis of Renal high frequency compared with the frequency of progressive papil-Cell Carcinoma: 1997 Workshop,'' Rochester, lary carcinoma. Their known genetic abnormalities (typically 0Y,
📜 SIMILAR VOLUMES
Category III, the final category applies to those factors that show some promise but do not meet the above criteria.
cause they may be impractical, expensive, or unproven. Group II is an intermediate group expected to be available in the near future and Presented at ''Diagnosis and Prognosis of Renal characterized by greater requirements for time, money, and other Cell Carcinoma: 1997 Workshop,'' Rochester, resour
C hemoprevention refers to the prevention of cancer or reduction of risk in susceptible individuals by the administration of natural or synthetic drugs with minimal toxicity to suppress, delay, or reverse carcinogenesis. 1 Chemoprevention is most effective in the early stages of cancer formation whe
This paper presents the conclusions of a workshop entitled 'Impact of Molecular Genetics on the Classification of Renal Cell Tumours', which was held in Heidelberg in October 1996. The focus on 'renal cell tumours' excludes any discussion of Wilms' tumour and its variants, or of tumours metastatic t